Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q2
02:18pm, Thursday, 04'th Aug 2022
Bayer (BAYRY) beats estimates for both earnings and revenues in the second quarter of 2022.
Bayer says arbitration ruling over BASF claims is imminent
10:49am, Thursday, 04'th Aug 2022
Bayer's chief executive said an arbitration court would soon decide on claims brought by rival BASF, saying it overpaid for assets that Bayer sold to secure antitrust clearance for the takeover of Mon
Bayer's agriculture unit, consumer health drives improved outlook for 2022
01:49am, Thursday, 04'th Aug 2022
Agriculture and pharmaceuticals company Bayer on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products.
Johnson & Johnson Has Been Posting Negative Surprises: A Look Under The Hood
08:06pm, Monday, 18'th Jul 2022
JNJ Management expects relatively consistent growth for the rest of the year.
3 Drugmaker Stocks Worth Buying to Boost Your Portfolio Health
10:45am, Wednesday, 13'th Jul 2022
Merck (MRK), Bayer (BAYRY) and Jazz Pharmaceuticals (JAZZ) are three large drugmakers that are good stocks to buy.
BAYRY vs. RHHBY: Which Stock Is the Better Value Option?
01:06pm, Tuesday, 12'th Jul 2022
BAYRY vs. RHHBY: Which Stock Is the Better Value Option?
IQ-AI signs partnership with Bayer to provide its software
03:24am, Monday, 11'th Jul 2022
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) said its medical imaging analysis software, IB Clinic, is now available on the Bayer Calantic platform. Bayer Calantic includes a suite of apps that help manage a ra
Bayer, BASF win new trial on $60 million damage award in weedkiller lawsuit
02:12pm, Thursday, 07'th Jul 2022
Bayer AG and BASF have won a new trial on $60 million in punitive damages they were ordered to pay a Missouri peach farmer who said dicamba, a herbicide they produced, drifted onto his orchard and har
Oncology ABCs: A Small-Cap Biopharma Prospectus Series
09:30am, Monday, 04'th Jul 2022
Oncology remains the fastest growing pharma segment, where innovation is largely driven by emerging small companies. The global oncology market is estimated at c US$175–180bn and is anticipated to m
Bayer: Risk/Reward Skewed To The Upside
09:25am, Saturday, 02'nd Jul 2022
Bayer AG is one of the world's largest “life-science” conglomerates. For a global company with such a strong global presence and portfolio of valuable intellectual property, Bayer stock is trading
U.S. Supreme Court again nixes Bayer challenge to weedkiller suits
10:06am, Monday, 27'th Jun 2022
(Reuters) -The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries
Bayer's attempt to end Roundup lawsuits rejected by US Supreme Court
07:46am, Wednesday, 22'nd Jun 2022
The US Supreme Court has rejected a bid by Bayer AG (ETR:BAYN, OTC:BAYZF) to dismiss lawsuits by customers alleging the company's Roundup weedkiller causes cancer, a move that could cost the chemical
Supreme Court rejects Bayer's bid to stop Roundup weedkiller lawsuits
12:41pm, Tuesday, 21'st Jun 2022
The justices left in place a $25 million judgment in favor of a California man who says he developed cancer from using Roundup for decades on his San Francisco Bay Area property.
Supreme Court rejects Bayer bid to stop Roundup lawsuits
10:01am, Tuesday, 21'st Jun 2022
The Supreme Court has rejected Bayer's appeal to shut down thousands of lawsuits claiming that its Roundup weedkiller causes cancer.
U.S. Supreme Court rejects Bayer bid to nix Roundup weedkiller suits
09:47am, Tuesday, 21'st Jun 2022
The U.S. Supreme Court on Tuesday rejected Bayer AG's bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German company seeks to avoid potentially billion
